SODIUM 2,6-DITERT-BUTYL NAPHTANATE SULFONATE

( ARTG ) Fonat is indicated for the treatment of: Osteoporosis, including glucocorticoid-induced osteoporosis. Fonat is indicated for the prevention of Glucocorticoid-induced osteoporosis in those patients on long term corticosteroid therapy (see Clinical Trials, Glucorticoid-Induced Osteoporosis). Prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the mean for young adults (gender specific), or by: - the presence of osteoporotic fracture.